Literature DB >> 18645527

The prevalence of gastrointestinal diseases in Israeli adolescents and its association with body mass index, gender, and Jewish ethnicity.

Dan-Avi Landau1, Avishy Goldberg, Zohar Levi, Yehezkel Levy, Yaron Niv, Yosefa Bar-Dayan.   

Abstract

OBJECTIVE: The objectives of this study were to describe gastrointestinal (GI) disease prevalence in Israeli adolescents, and possible associations between prevalence and body mass index (BMI), sex and Jewish ethnicity.
DESIGN: A retrospective analysis of screening for GI disease performed by the Israeli Defense Forces recruiting office between 1998 and 2003.
SETTING: Screening was performed at the recruiting office, and included detailed history and physical examination performed by a general practitioner. Further testing was performed as needed and the final diagnosis was established by a gastroenterologist at the recruiting office. PATIENTS: Seventeen-year-old Israeli nationals.
RESULTS: During the study period, 466,855 (58.5% male) adolescents were screened for GI disease. Peptic ulcer disease, irritable bowel syndrome, and nonulcer dyspepsia were the most prevalent disorders affecting 466/10, 460/10, and 296/10, respectively. There was an increase in the prevalence of lactose intolerance during the study period and also an increase in the prevalence of peptic ulcer disease in females. The prevalence of inflammatory bowel disease has also increased from 100/10 to 149/10, although this trend failed to reach statistical significance (P=0.097). Higher BMI was associated with statistically significant higher prevalence rates of gastroesophageal reflux disease (P<0.05). A stronger association in females was found in gallbladder disease (P<0.001). Lower BMI was associated with higher prevalence rates of irritable bowel syndrome (P<0.001), and higher rates of inflammatory bowel disease and lactose intolerance in males (P<0.01 and <0.001, respectively).
CONCLUSIONS: GI diseases are not uncommon among adolescents, and for some disorders prevalence is rising. The association between BMI and prevalence has been further clarified.

Entities:  

Mesh:

Year:  2008        PMID: 18645527     DOI: 10.1097/MCG.0b013e31814685f9

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

2.  Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.

Authors:  Yasunori Yamamoto; Shinya Furukawa; Junichi Watanabe; Aki Kato; Katsunori Kusumoto; Teruki Miyake; Eiji Takeshita; Yoshio Ikeda; Naofumi Yamamoto; Yuka Saeki; Yoichi Hiasa
Journal:  Int J Colorectal Dis       Date:  2022-10-20       Impact factor: 2.796

3.  A comparison of diagnostic tests for lactose malabsorption--which one is the best?

Authors:  Øistein Hovde; Per G Farup
Journal:  BMC Gastroenterol       Date:  2009-10-31       Impact factor: 3.067

4.  A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland.

Authors:  Helen Steed; Shaun Walsh; Nigel Reynolds
Journal:  Obes Facts       Date:  2009-12-17       Impact factor: 3.942

Review 5.  Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.

Authors:  Jan Bilski; Agnieszka Mazur-Bialy; Dagmara Wojcik; Marcin Surmiak; Marcin Magierowski; Zbigniew Sliwowski; Robert Pajdo; Slawomir Kwiecien; Aleksandra Danielak; Agata Ptak-Belowska; Thomas Brzozowski
Journal:  Biomolecules       Date:  2019-11-26

Review 6.  The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders.

Authors:  Maafi R Islam; Subha Arthur; Jennifer Haynes; Molly R Butts; Niraj Nepal; Uma Sundaram
Journal:  Nutrients       Date:  2022-01-31       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.